Home » Severe asthma, new biologic drug approved in Europe

Severe asthma, new biologic drug approved in Europe

by admin
Severe asthma, new biologic drug approved in Europe

About 300,000 adults and children suffer from severe asthma in Italy. For them now comes the news of the European approval of a new drug to be used as an additional maintenance therapy in patients from the age of 12. Approval in the European Union follows the recommendation of the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) of July 2022.

See also  Colorectal cancer: glucose 'double game' discovered

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy